NCT06903715View on ClinicalTrials.gov

A Clinical Study of Belzutifan (MK-6482) Alone or With Phenytoin in Healthy Participants (CA46602/MK-6482-035)

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

March 28, 2025

Primary Completion Date

May 8, 2025

Study Completion Date

May 27, 2025

Conditions

Healthy

Interventions

DRUG

Belzutifan

Oral administration

DRUG

Phenytoin

Oral administration

Trial Locations (1)

85283

Celerion, Inc. ( Site 0001), Tempe

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY